US: Pfizer "nearing" sale of infant-nutrition business
Pfizer "nearing" baby food sale
The US pharmaceutical company has previously confirmed to just-food that it is "considering strategic options" for the business, including a "sale, spin-off or other transaction".
According to a report in the Wall Street Journal, Pfizer has stuck an agreement to sell the unit to Nestle for US$9bn. Meanwhile, other reports have suggested that Nestle and Danone have both submitted competing bids, valuing the business at around $10bn.
Pfizer is expected to announce a sale of the unit next week.
Last week brought further evidence of the difficulties facing food manufacturers as they look to grow their businesses in the developed markets of the US and Europe....
just-food last week brought live coverage from the GMA/FMI Sustainability Summit in Washington DC where presentations were given from members of the Environmental Defense Fund, the Rainforest Alliance...
- Mondelez results and outlook - 7 things to learn
- Comment: Hain Celestial cognisant of US challenges
- Why Lactalis swooped for Romanian dairy Albalact
- What should you learn from 2015 olive oil prices?
- Can Yildiz's new snacks unit match its ambitions?
- Mondelez continues to see margins up, sales mixed
- Hain Celestial lifted by international, protein
- China eyes further infant formula restrictions
- Coca-Cola to invest in Nigerian dairy group Chi
- Unilever launches eggless Hellmann's mayo in US